VCRE Short Volume

Vicore Pharma Holding AB (VCRE) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $3.49B, listed on NASDAQ, employing roughly 40 people, carrying a beta of 0.15 to the broader market. Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Led by Ahmed Mousa, public since 2026-07-02.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-07-16
Short Volume
930
Total Volume
3.3K
Short %
28.24%
30-Day Avg Short %
37.19%

Showing 9 days of FINRA short volume data for Vicore Pharma Holding AB.

Learn how short volume is reported and how to read the data →

Frequently asked VCRE short volume questions

What is the daily VCRE short volume?
As of Jul 16, 2026, Vicore Pharma Holding AB (VCRE) short volume is 930 shares against 3.3K total reported volume, or 28.24% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is VCRE short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does VCRE short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.